Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PARDES BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 13.6M | $20.4M | $1.50 | Apr 5, 2023 | Indirect |
Theseus Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1.39M | $4.23M | $3.05 | Jul 17, 2023 | Indirect |
ALUMIS INC. | 10%+ Owner | Common Stock | 4.2M | Jul 1, 2024 | Indirect | ||
ALUMIS INC. | 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | Jul 1, 2024 | Indirect | ||
ALUMIS INC. | 10%+ Owner | Series B-1 Redeemable Convertible Preferred Stock | 0 | Jul 1, 2024 | Indirect | ||
ALUMIS INC. | 10%+ Owner | Series B-2 Redeemable Convertible Preferred Stock | 0 | Jul 1, 2024 | Indirect | ||
ALUMIS INC. | 10%+ Owner | Series C Redeemable Convertible Preferred Stock | 0 | Jul 1, 2024 | Indirect | ||
ALUMIS INC. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | Jul 1, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALMS | ALUMIS INC. | Jul 1, 2024 | 32 | $40M | 4 | Jul 3, 2024 | 10%+ Owner |
ALMS | ALUMIS INC. | Jun 27, 2024 | 0 | $0 | 3 | Jun 27, 2024 | 10%+ Owner |
THRX | Theseus Pharmaceuticals, Inc. | Jul 17, 2023 | 2 | $2.08M | 4 | Jul 19, 2023 | 10%+ Owner |
PRDS | PARDES BIOSCIENCES, INC. | Apr 5, 2023 | 1 | $1.16M | 4 | Apr 6, 2023 | 10%+ Owner |
THRX | Theseus Pharmaceuticals, Inc. | Dec 29, 2022 | 2 | $2.5M | 4 | Jan 3, 2023 | 10%+ Owner |
PRDS | PARDES BIOSCIENCES, INC. | Dec 1, 2022 | 1 | $542K | 4 | Dec 5, 2022 | 10%+ Owner |
THRX | Theseus Pharmaceuticals, Inc. | Jun 9, 2022 | 0 | $0 | 3 | Jun 13, 2022 | 10%+ Owner |